These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1869824)

  • 1. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL; Watts LM; Lambert LE
    Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
    Ikeda K; Katagiri M
    Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE; Liu Z; Suciu-Foca N
    J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility.
    Gao X; Gazit E; Livneh A; Stastny P
    J Rheumatol; 1991 Jun; 18(6):801-3. PubMed ID: 1895259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
    Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
    J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
    Ostrov D; Krieger J; Sidney J; Sette A; Concannon P
    J Immunol; 1993 May; 150(10):4277-83. PubMed ID: 8482836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
    Roche PA; Cresswell P
    J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.